As indicated in the latest market research report published by IMARC Group, titled "India Anti-Obesity Drugs Market Report by Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs), Drug Type (Prescription Drugs, OTC Drugs), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2025-2033," The report offers a comprehensive analysis of the industry, including India anti-obesity drugs market growth, share, trends, and regional insights.
Market Size & Future Growth Potential:
The India anti-obesity drugs market size reached USD 80.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 190.0 Million by 2033, exhibiting a growth rate (CAGR) of 9.9% during 2025-2033.
Note: “We are currently updating our reports to the 2026–2034 period. If you need the latest data, information, and industry insights, please click on “Request Free Sample Report”
Recent News and Developments:
Eli Lilly's Market Entry (July 2024): Eli Lilly obtained approvals for importing and distributing tirzepatide-based weight-loss medications Zepbound and Mounjaro in India, marking a significant milestone in the country's anti-obesity drug landscape.
Biosimilar Launch by Glenmark (2024): Glenmark Pharmaceuticals launched Lirafit, a biosimilar version of liraglutide, making GLP-1 receptor agonist therapy more accessible and affordable for Indian patients.
Government Production Incentives: India announced plans to offer production-linked incentives (PLI) for local manufacturing of GLP-1 drugs targeting diabetes and obesity by 2026, aiming to reduce import dependency and increase affordability.
Novo Nordisk's Semaglutide Launch: The company launched semaglutide for obesity treatment in India, expanding treatment options for patients who have struggled with traditional weight management approaches.
Market Inflection Point Recognition: Industry experts have identified 2024 as a pivotal year for obesity medication markets globally, with increasing recognition of obesity as a treatable medical condition requiring pharmaceutical intervention.
Digital Health Integration: Online pharmacy platforms and telemedicine services are increasingly incorporating anti-obesity medications into their offerings, improving accessibility for patients across different geographical regions.
Request Free Sample Report: https://www.imarcgroup.com/india-anti-obesity-drugs-market/requestsample
India Anti-Obesity Drugs Market Trends:
The India Anti-Obesity Drugs Market is witnessing notable transformation as rising awareness of metabolic health and lifestyle-related disorders pushes more individuals toward medical weight management solutions. One of the strongest trends shaping the sector is the growing acceptance of prescription-based anti-obesity medications, driven by increasing consultations with endocrinologists, obesity specialists, and preventive healthcare providers. Moreover, demand for modern drug classes—such as GLP-1 receptor agonists and appetite-regulating formulations—is growing rapidly due to their improved safety profiles and clinically proven weight reduction outcomes. Additionally, digital health platforms and teleconsultation services are making obesity management more accessible by offering online assessments, doctor-issued e-prescriptions, and virtual progress monitoring.
In addition, overweight and obesity prevalence among younger populations is leading to increased awareness campaigns that encourage early medical intervention rather than relying solely on fad diets. Pharmaceutical companies are also expanding research into combination therapies that target metabolism, hunger hormones, and fat absorption simultaneously. Furthermore, the shift toward personalized treatment plans—supported by genetic insights, lifestyle data, and AI-driven health analytics—is becoming more common. Together, these trends reflect a market moving toward scientifically backed, patient-centric, and digitally integrated obesity treatment solutions.
Market Scope and Growth Factors:
The India Anti-Obesity Drugs Market continues to expand steadily due to rising obesity rates, increased healthcare spending, and growing acceptance of medical weight-loss therapies. Sedentary lifestyles, high-calorie diets, and stress-induced eating habits are contributing to higher incidence of obesity, prompting more individuals to seek pharmaceutical support. Moreover, the expansion of private healthcare facilities and specialty obesity clinics is improving access to qualified professionals who can prescribe and monitor anti-obesity medications. Additionally, increased awareness of obesity’s link to chronic diseases—such as diabetes, cardiovascular disorders, PCOS, and joint issues—is motivating patients to adopt early pharmacological interventions.
In addition, supportive government programs promoting preventive health, wellness screenings, and non-communicable disease management are indirectly boosting the uptake of anti-obesity drugs. Growing penetration of health insurance, which increasingly covers obesity-related treatments, is also encouraging more patients to pursue structured medical support. Pharmaceutical companies are investing heavily in R&D, clinical trials, and market expansion to introduce next-generation anti-obesity drugs in India. Furthermore, rising adoption of telehealth platforms and digital monitoring tools is making long-term adherence easier for patients and more manageable for clinicians. Together, these growth drivers ensure that the India Anti-Obesity Drugs Market remains on a strong upward trajectory—supported by lifestyle shifts, clinical innovation, and India’s increased focus on long-term metabolic health.
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/india-anti-obesity-drugs-market
Comprehensive Market Report Highlights & Segmentation Analysis:
The market report offers a comprehensive analysis of the segments, highlighting those with the largest India Anti-Obesity Drugs Market Share. It includes forecasts for the period 2025-2033 and historical data from 2019-2024 for the following segments.
Segmentation by Drug Class:
Peripherally Acting Drugs
Centrally Acting Drugs
Segmentation by Drug Type:
Prescription Drugs
OTC Drugs
Segmentation by Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Segmentation by Regional:
North India
South India
East India
West India
Competitor Landscape:
The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.
Discuss Your Needs with Our Analyst -- Inquire or Customize Now: https://www.imarcgroup.com/request?type=report&id=31634&flag=E
Key highlights of the Report:
Historical Market Performance
Future Market Projections
Impact of COVID-19 on Market Dynamics
Industry Competitive Analysis (Porter's Five Forces)
Market Dynamics and Growth Drivers
SWOT Analysis (Strengths, Weaknesses, Opportunities, Threats)
Market Ecosystem and Value Creation Framework
Competitive Positioning and Benchmarking Strategies
Major Advantages of the Report:
This report provides market leaders and new entrants with accurate revenue estimates for the overall market and its key subsegments.
Stakeholders can leverage this report to gain a deeper understanding of the competitive landscape, enabling them to strategically position their businesses and develop effective go-to-market strategies.
The report provides stakeholders with valuable insights into the market dynamics, offering a comprehensive analysis of key drivers, restraints, challenges, and opportunities.
Why Choose IMARC Group:
Extensive Industry Expertise
Robust Research Methodology
Insightful Data-Driven Analysis
Precise Forecasting Capabilities
Established Track Record of Success
Reach with an Extensive Network
Tailored Solutions to Meet Client Needs
Commitment to Strong Client Relationships and Focus
Timely Project Delivery
Cost-Effective Service Options
Note: Should you require specific information not included in the current report, we are pleased to offer customization options to meet your needs.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: +1-201971-6302 | Africa and Europe: +44-702-409-7331
Write a comment ...